Global Point-of-care Testing (POCT) for Substance Abuse Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Point-of-care Testing (POCT) for Substance Abuse market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Point-of-care Testing (POCT) for Substance Abuse is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Point-of-care Testing (POCT) for Substance Abuse is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Point-of-care Testing (POCT) for Substance Abuse is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Point-of-care Testing (POCT) for Substance Abuse players cover Roche, Danaher, Abbott, Siemens, Beijing Hotgen Biotech, Hangzhou Biotest Biotech CO.,LTD, Assure Tech, Orient Gene and Thermo Fisher, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Point-of-care Testing (POCT) for Substance Abuse Industry Forecast” looks at past sales and reviews total world Point-of-care Testing (POCT) for Substance Abuse sales in 2022, providing a comprehensive analysis by region and market sector of projected Point-of-care Testing (POCT) for Substance Abuse sales for 2023 through 2029. With Point-of-care Testing (POCT) for Substance Abuse sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-care Testing (POCT) for Substance Abuse industry.
This Insight Report provides a comprehensive analysis of the global Point-of-care Testing (POCT) for Substance Abuse landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-care Testing (POCT) for Substance Abuse portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point-of-care Testing (POCT) for Substance Abuse market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-care Testing (POCT) for Substance Abuse and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-care Testing (POCT) for Substance Abuse.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-care Testing (POCT) for Substance Abuse market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Point-of-care Testing (POCT) for Substance Abuse market?
What factors are driving Point-of-care Testing (POCT) for Substance Abuse market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Point-of-care Testing (POCT) for Substance Abuse market opportunities vary by end market size?
How does Point-of-care Testing (POCT) for Substance Abuse break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Point-of-care Testing (POCT) for Substance Abuse market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Point-of-care Testing (POCT) for Substance Abuse is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Point-of-care Testing (POCT) for Substance Abuse is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Point-of-care Testing (POCT) for Substance Abuse is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Point-of-care Testing (POCT) for Substance Abuse players cover Roche, Danaher, Abbott, Siemens, Beijing Hotgen Biotech, Hangzhou Biotest Biotech CO.,LTD, Assure Tech, Orient Gene and Thermo Fisher, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Point-of-care Testing (POCT) for Substance Abuse Industry Forecast” looks at past sales and reviews total world Point-of-care Testing (POCT) for Substance Abuse sales in 2022, providing a comprehensive analysis by region and market sector of projected Point-of-care Testing (POCT) for Substance Abuse sales for 2023 through 2029. With Point-of-care Testing (POCT) for Substance Abuse sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-care Testing (POCT) for Substance Abuse industry.
This Insight Report provides a comprehensive analysis of the global Point-of-care Testing (POCT) for Substance Abuse landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-care Testing (POCT) for Substance Abuse portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point-of-care Testing (POCT) for Substance Abuse market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-care Testing (POCT) for Substance Abuse and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-care Testing (POCT) for Substance Abuse.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-care Testing (POCT) for Substance Abuse market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Based on Colloidal Gold
- Based on Fluorescence Immunochromatography
- Hospital
- Diagnostic Center
- Road Traffic Safety
- Military
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Danaher
- Abbott
- Siemens
- Beijing Hotgen Biotech
- Hangzhou Biotest Biotech CO.,LTD
- Assure Tech
- Orient Gene
- Thermo Fisher
- Guangzhou Wondfo Biotech Co.,Ltd.
- Hangzhou Alltest Biotech Co.,Ltd.
- Beckman Coulter
- Bio-Rad
- BioMerieux
What is the 10-year outlook for the global Point-of-care Testing (POCT) for Substance Abuse market?
What factors are driving Point-of-care Testing (POCT) for Substance Abuse market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Point-of-care Testing (POCT) for Substance Abuse market opportunities vary by end market size?
How does Point-of-care Testing (POCT) for Substance Abuse break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Point-of-care Testing (POCT) for Substance Abuse by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Point-of-care Testing (POCT) for Substance Abuse by Country/Region, 2018, 2022 & 2029
2.2 Point-of-care Testing (POCT) for Substance Abuse Segment by Type
2.2.1 Based on Colloidal Gold
2.2.2 Based on Fluorescence Immunochromatography
2.3 Point-of-care Testing (POCT) for Substance Abuse Sales by Type
2.3.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2018-2023)
2.3.2 Global Point-of-care Testing (POCT) for Substance Abuse Revenue and Market Share by Type (2018-2023)
2.3.3 Global Point-of-care Testing (POCT) for Substance Abuse Sale Price by Type (2018-2023)
2.4 Point-of-care Testing (POCT) for Substance Abuse Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Center
2.4.3 Road Traffic Safety
2.4.4 Military
2.4.5 Others
2.5 Point-of-care Testing (POCT) for Substance Abuse Sales by Application
2.5.1 Global Point-of-care Testing (POCT) for Substance Abuse Sale Market Share by Application (2018-2023)
2.5.2 Global Point-of-care Testing (POCT) for Substance Abuse Revenue and Market Share by Application (2018-2023)
2.5.3 Global Point-of-care Testing (POCT) for Substance Abuse Sale Price by Application (2018-2023)
3 GLOBAL POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE BY COMPANY
3.1 Global Point-of-care Testing (POCT) for Substance Abuse Breakdown Data by Company
3.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Annual Sales by Company (2018-2023)
3.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Company (2018-2023)
3.2 Global Point-of-care Testing (POCT) for Substance Abuse Annual Revenue by Company (2018-2023)
3.2.1 Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Company (2018-2023)
3.2.2 Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Company (2018-2023)
3.3 Global Point-of-care Testing (POCT) for Substance Abuse Sale Price by Company
3.4 Key Manufacturers Point-of-care Testing (POCT) for Substance Abuse Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Point-of-care Testing (POCT) for Substance Abuse Product Location Distribution
3.4.2 Players Point-of-care Testing (POCT) for Substance Abuse Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE BY GEOGRAPHIC REGION
4.1 World Historic Point-of-care Testing (POCT) for Substance Abuse Market Size by Geographic Region (2018-2023)
4.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Point-of-care Testing (POCT) for Substance Abuse Market Size by Country/Region (2018-2023)
4.2.1 Global Point-of-care Testing (POCT) for Substance Abuse Annual Sales by Country/Region (2018-2023)
4.2.2 Global Point-of-care Testing (POCT) for Substance Abuse Annual Revenue by Country/Region (2018-2023)
4.3 Americas Point-of-care Testing (POCT) for Substance Abuse Sales Growth
4.4 APAC Point-of-care Testing (POCT) for Substance Abuse Sales Growth
4.5 Europe Point-of-care Testing (POCT) for Substance Abuse Sales Growth
4.6 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Growth
5 AMERICAS
5.1 Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Country
5.1.1 Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2018-2023)
5.1.2 Americas Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2018-2023)
5.2 Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Type
5.3 Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Region
6.1.1 APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2018-2023)
6.1.2 APAC Point-of-care Testing (POCT) for Substance Abuse Revenue by Region (2018-2023)
6.2 APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Type
6.3 APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Point-of-care Testing (POCT) for Substance Abuse by Country
7.1.1 Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2018-2023)
7.1.2 Europe Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2018-2023)
7.2 Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Type
7.3 Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse by Country
8.1.1 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2018-2023)
8.1.2 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2018-2023)
8.2 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Type
8.3 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Substance Abuse
10.3 Manufacturing Process Analysis of Point-of-care Testing (POCT) for Substance Abuse
10.4 Industry Chain Structure of Point-of-care Testing (POCT) for Substance Abuse
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Point-of-care Testing (POCT) for Substance Abuse Distributors
11.3 Point-of-care Testing (POCT) for Substance Abuse Customer
12 WORLD FORECAST REVIEW FOR POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE BY GEOGRAPHIC REGION
12.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Region
12.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Forecast by Region (2024-2029)
12.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Point-of-care Testing (POCT) for Substance Abuse Forecast by Type
12.7 Global Point-of-care Testing (POCT) for Substance Abuse Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.1.3 Roche Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Danaher
13.2.1 Danaher Company Information
13.2.2 Danaher Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.2.3 Danaher Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Danaher Main Business Overview
13.2.5 Danaher Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.3.3 Abbott Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Siemens
13.4.1 Siemens Company Information
13.4.2 Siemens Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.4.3 Siemens Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Siemens Main Business Overview
13.4.5 Siemens Latest Developments
13.5 Beijing Hotgen Biotech
13.5.1 Beijing Hotgen Biotech Company Information
13.5.2 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.5.3 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Beijing Hotgen Biotech Main Business Overview
13.5.5 Beijing Hotgen Biotech Latest Developments
13.6 Hangzhou Biotest Biotech CO.,LTD
13.6.1 Hangzhou Biotest Biotech CO.,LTD Company Information
13.6.2 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.6.3 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hangzhou Biotest Biotech CO.,LTD Main Business Overview
13.6.5 Hangzhou Biotest Biotech CO.,LTD Latest Developments
13.7 Assure Tech
13.7.1 Assure Tech Company Information
13.7.2 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.7.3 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Assure Tech Main Business Overview
13.7.5 Assure Tech Latest Developments
13.8 Orient Gene
13.8.1 Orient Gene Company Information
13.8.2 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.8.3 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Orient Gene Main Business Overview
13.8.5 Orient Gene Latest Developments
13.9 Thermo Fisher
13.9.1 Thermo Fisher Company Information
13.9.2 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.9.3 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Thermo Fisher Main Business Overview
13.9.5 Thermo Fisher Latest Developments
13.10 Guangzhou Wondfo Biotech Co.,Ltd.
13.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Information
13.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Main Business Overview
13.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Latest Developments
13.11 Hangzhou Alltest Biotech Co.,Ltd.
13.11.1 Hangzhou Alltest Biotech Co.,Ltd. Company Information
13.11.2 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.11.3 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hangzhou Alltest Biotech Co.,Ltd. Main Business Overview
13.11.5 Hangzhou Alltest Biotech Co.,Ltd. Latest Developments
13.12 Beckman Coulter
13.12.1 Beckman Coulter Company Information
13.12.2 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.12.3 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Beckman Coulter Main Business Overview
13.12.5 Beckman Coulter Latest Developments
13.13 Bio-Rad
13.13.1 Bio-Rad Company Information
13.13.2 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.13.3 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Bio-Rad Main Business Overview
13.13.5 Bio-Rad Latest Developments
13.14 BioMerieux
13.14.1 BioMerieux Company Information
13.14.2 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.14.3 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 BioMerieux Main Business Overview
13.14.5 BioMerieux Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Point-of-care Testing (POCT) for Substance Abuse by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Point-of-care Testing (POCT) for Substance Abuse by Country/Region, 2018, 2022 & 2029
2.2 Point-of-care Testing (POCT) for Substance Abuse Segment by Type
2.2.1 Based on Colloidal Gold
2.2.2 Based on Fluorescence Immunochromatography
2.3 Point-of-care Testing (POCT) for Substance Abuse Sales by Type
2.3.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2018-2023)
2.3.2 Global Point-of-care Testing (POCT) for Substance Abuse Revenue and Market Share by Type (2018-2023)
2.3.3 Global Point-of-care Testing (POCT) for Substance Abuse Sale Price by Type (2018-2023)
2.4 Point-of-care Testing (POCT) for Substance Abuse Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Center
2.4.3 Road Traffic Safety
2.4.4 Military
2.4.5 Others
2.5 Point-of-care Testing (POCT) for Substance Abuse Sales by Application
2.5.1 Global Point-of-care Testing (POCT) for Substance Abuse Sale Market Share by Application (2018-2023)
2.5.2 Global Point-of-care Testing (POCT) for Substance Abuse Revenue and Market Share by Application (2018-2023)
2.5.3 Global Point-of-care Testing (POCT) for Substance Abuse Sale Price by Application (2018-2023)
3 GLOBAL POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE BY COMPANY
3.1 Global Point-of-care Testing (POCT) for Substance Abuse Breakdown Data by Company
3.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Annual Sales by Company (2018-2023)
3.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Company (2018-2023)
3.2 Global Point-of-care Testing (POCT) for Substance Abuse Annual Revenue by Company (2018-2023)
3.2.1 Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Company (2018-2023)
3.2.2 Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Company (2018-2023)
3.3 Global Point-of-care Testing (POCT) for Substance Abuse Sale Price by Company
3.4 Key Manufacturers Point-of-care Testing (POCT) for Substance Abuse Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Point-of-care Testing (POCT) for Substance Abuse Product Location Distribution
3.4.2 Players Point-of-care Testing (POCT) for Substance Abuse Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE BY GEOGRAPHIC REGION
4.1 World Historic Point-of-care Testing (POCT) for Substance Abuse Market Size by Geographic Region (2018-2023)
4.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Point-of-care Testing (POCT) for Substance Abuse Market Size by Country/Region (2018-2023)
4.2.1 Global Point-of-care Testing (POCT) for Substance Abuse Annual Sales by Country/Region (2018-2023)
4.2.2 Global Point-of-care Testing (POCT) for Substance Abuse Annual Revenue by Country/Region (2018-2023)
4.3 Americas Point-of-care Testing (POCT) for Substance Abuse Sales Growth
4.4 APAC Point-of-care Testing (POCT) for Substance Abuse Sales Growth
4.5 Europe Point-of-care Testing (POCT) for Substance Abuse Sales Growth
4.6 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Growth
5 AMERICAS
5.1 Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Country
5.1.1 Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2018-2023)
5.1.2 Americas Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2018-2023)
5.2 Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Type
5.3 Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Region
6.1.1 APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2018-2023)
6.1.2 APAC Point-of-care Testing (POCT) for Substance Abuse Revenue by Region (2018-2023)
6.2 APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Type
6.3 APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Point-of-care Testing (POCT) for Substance Abuse by Country
7.1.1 Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2018-2023)
7.1.2 Europe Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2018-2023)
7.2 Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Type
7.3 Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse by Country
8.1.1 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2018-2023)
8.1.2 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2018-2023)
8.2 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Type
8.3 Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Substance Abuse
10.3 Manufacturing Process Analysis of Point-of-care Testing (POCT) for Substance Abuse
10.4 Industry Chain Structure of Point-of-care Testing (POCT) for Substance Abuse
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Point-of-care Testing (POCT) for Substance Abuse Distributors
11.3 Point-of-care Testing (POCT) for Substance Abuse Customer
12 WORLD FORECAST REVIEW FOR POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE BY GEOGRAPHIC REGION
12.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Region
12.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Forecast by Region (2024-2029)
12.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Point-of-care Testing (POCT) for Substance Abuse Forecast by Type
12.7 Global Point-of-care Testing (POCT) for Substance Abuse Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.1.3 Roche Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Danaher
13.2.1 Danaher Company Information
13.2.2 Danaher Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.2.3 Danaher Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Danaher Main Business Overview
13.2.5 Danaher Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.3.3 Abbott Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Siemens
13.4.1 Siemens Company Information
13.4.2 Siemens Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.4.3 Siemens Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Siemens Main Business Overview
13.4.5 Siemens Latest Developments
13.5 Beijing Hotgen Biotech
13.5.1 Beijing Hotgen Biotech Company Information
13.5.2 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.5.3 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Beijing Hotgen Biotech Main Business Overview
13.5.5 Beijing Hotgen Biotech Latest Developments
13.6 Hangzhou Biotest Biotech CO.,LTD
13.6.1 Hangzhou Biotest Biotech CO.,LTD Company Information
13.6.2 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.6.3 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hangzhou Biotest Biotech CO.,LTD Main Business Overview
13.6.5 Hangzhou Biotest Biotech CO.,LTD Latest Developments
13.7 Assure Tech
13.7.1 Assure Tech Company Information
13.7.2 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.7.3 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Assure Tech Main Business Overview
13.7.5 Assure Tech Latest Developments
13.8 Orient Gene
13.8.1 Orient Gene Company Information
13.8.2 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.8.3 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Orient Gene Main Business Overview
13.8.5 Orient Gene Latest Developments
13.9 Thermo Fisher
13.9.1 Thermo Fisher Company Information
13.9.2 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.9.3 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Thermo Fisher Main Business Overview
13.9.5 Thermo Fisher Latest Developments
13.10 Guangzhou Wondfo Biotech Co.,Ltd.
13.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Information
13.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Main Business Overview
13.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Latest Developments
13.11 Hangzhou Alltest Biotech Co.,Ltd.
13.11.1 Hangzhou Alltest Biotech Co.,Ltd. Company Information
13.11.2 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.11.3 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hangzhou Alltest Biotech Co.,Ltd. Main Business Overview
13.11.5 Hangzhou Alltest Biotech Co.,Ltd. Latest Developments
13.12 Beckman Coulter
13.12.1 Beckman Coulter Company Information
13.12.2 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.12.3 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Beckman Coulter Main Business Overview
13.12.5 Beckman Coulter Latest Developments
13.13 Bio-Rad
13.13.1 Bio-Rad Company Information
13.13.2 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.13.3 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Bio-Rad Main Business Overview
13.13.5 Bio-Rad Latest Developments
13.14 BioMerieux
13.14.1 BioMerieux Company Information
13.14.2 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
13.14.3 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 BioMerieux Main Business Overview
13.14.5 BioMerieux Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Point-of-care Testing (POCT) for Substance Abuse Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Point-of-care Testing (POCT) for Substance Abuse Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Based on Colloidal Gold
Table 4. Major Players of Based on Fluorescence Immunochromatography
Table 5. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Type (2018-2023) & (K Units)
Table 6. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2018-2023)
Table 7. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Type (2018-2023) & ($ million)
Table 8. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Type (2018-2023)
Table 9. Global Point-of-care Testing (POCT) for Substance Abuse Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Application (2018-2023) & (K Units)
Table 11. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2018-2023)
Table 12. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Application (2018-2023)
Table 13. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Application (2018-2023)
Table 14. Global Point-of-care Testing (POCT) for Substance Abuse Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Company (2018-2023) & (K Units)
Table 16. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Company (2018-2023)
Table 17. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Company (2018-2023)
Table 19. Global Point-of-care Testing (POCT) for Substance Abuse Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Point-of-care Testing (POCT) for Substance Abuse Producing Area Distribution and Sales Area
Table 21. Players Point-of-care Testing (POCT) for Substance Abuse Products Offered
Table 22. Point-of-care Testing (POCT) for Substance Abuse Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share Geographic Region (2018-2023)
Table 27. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country/Region (2018-2023)
Table 31. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2018-2023) & (K Units)
Table 34. Americas Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country (2018-2023)
Table 35. Americas Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country (2018-2023)
Table 37. Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Type (2018-2023) & (K Units)
Table 38. Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Application (2018-2023) & (K Units)
Table 39. APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2018-2023) & (K Units)
Table 40. APAC Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region (2018-2023)
Table 41. APAC Point-of-care Testing (POCT) for Substance Abuse Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Region (2018-2023)
Table 43. APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Type (2018-2023) & (K Units)
Table 44. APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Application (2018-2023) & (K Units)
Table 45. Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2018-2023) & (K Units)
Table 46. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country (2018-2023)
Table 47. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country (2018-2023)
Table 49. Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Type (2018-2023) & (K Units)
Table 50. Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Point-of-care Testing (POCT) for Substance Abuse
Table 58. Key Market Challenges & Risks of Point-of-care Testing (POCT) for Substance Abuse
Table 59. Key Industry Trends of Point-of-care Testing (POCT) for Substance Abuse
Table 60. Point-of-care Testing (POCT) for Substance Abuse Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Point-of-care Testing (POCT) for Substance Abuse Distributors List
Table 63. Point-of-care Testing (POCT) for Substance Abuse Customer List
Table 64. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Roche Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 79. Roche Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 80. Roche Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Danaher Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 84. Danaher Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 85. Danaher Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Danaher Main Business
Table 87. Danaher Latest Developments
Table 88. Abbott Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 90. Abbott Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Abbott Main Business
Table 92. Abbott Latest Developments
Table 93. Siemens Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 94. Siemens Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 95. Siemens Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Siemens Main Business
Table 97. Siemens Latest Developments
Table 98. Beijing Hotgen Biotech Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 99. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 100. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Beijing Hotgen Biotech Main Business
Table 102. Beijing Hotgen Biotech Latest Developments
Table 103. Hangzhou Biotest Biotech CO.,LTD Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 104. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 105. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Hangzhou Biotest Biotech CO.,LTD Main Business
Table 107. Hangzhou Biotest Biotech CO.,LTD Latest Developments
Table 108. Assure Tech Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 109. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 110. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Assure Tech Main Business
Table 112. Assure Tech Latest Developments
Table 113. Orient Gene Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 114. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 115. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Orient Gene Main Business
Table 117. Orient Gene Latest Developments
Table 118. Thermo Fisher Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 119. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 120. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Thermo Fisher Main Business
Table 122. Thermo Fisher Latest Developments
Table 123. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 124. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 125. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Guangzhou Wondfo Biotech Co.,Ltd. Main Business
Table 127. Guangzhou Wondfo Biotech Co.,Ltd. Latest Developments
Table 128. Hangzhou Alltest Biotech Co.,Ltd. Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 129. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 130. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Hangzhou Alltest Biotech Co.,Ltd. Main Business
Table 132. Hangzhou Alltest Biotech Co.,Ltd. Latest Developments
Table 133. Beckman Coulter Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 134. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 135. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Beckman Coulter Main Business
Table 137. Beckman Coulter Latest Developments
Table 138. Bio-Rad Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 139. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 140. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Bio-Rad Main Business
Table 142. Bio-Rad Latest Developments
Table 143. BioMerieux Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 144. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 145. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. BioMerieux Main Business
Table 147. BioMerieux Latest Developments
Table 1. Point-of-care Testing (POCT) for Substance Abuse Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Point-of-care Testing (POCT) for Substance Abuse Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Based on Colloidal Gold
Table 4. Major Players of Based on Fluorescence Immunochromatography
Table 5. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Type (2018-2023) & (K Units)
Table 6. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2018-2023)
Table 7. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Type (2018-2023) & ($ million)
Table 8. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Type (2018-2023)
Table 9. Global Point-of-care Testing (POCT) for Substance Abuse Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Application (2018-2023) & (K Units)
Table 11. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2018-2023)
Table 12. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Application (2018-2023)
Table 13. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Application (2018-2023)
Table 14. Global Point-of-care Testing (POCT) for Substance Abuse Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Company (2018-2023) & (K Units)
Table 16. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Company (2018-2023)
Table 17. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Company (2018-2023)
Table 19. Global Point-of-care Testing (POCT) for Substance Abuse Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Point-of-care Testing (POCT) for Substance Abuse Producing Area Distribution and Sales Area
Table 21. Players Point-of-care Testing (POCT) for Substance Abuse Products Offered
Table 22. Point-of-care Testing (POCT) for Substance Abuse Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share Geographic Region (2018-2023)
Table 27. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country/Region (2018-2023)
Table 31. Global Point-of-care Testing (POCT) for Substance Abuse Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2018-2023) & (K Units)
Table 34. Americas Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country (2018-2023)
Table 35. Americas Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country (2018-2023)
Table 37. Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Type (2018-2023) & (K Units)
Table 38. Americas Point-of-care Testing (POCT) for Substance Abuse Sales by Application (2018-2023) & (K Units)
Table 39. APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2018-2023) & (K Units)
Table 40. APAC Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region (2018-2023)
Table 41. APAC Point-of-care Testing (POCT) for Substance Abuse Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Region (2018-2023)
Table 43. APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Type (2018-2023) & (K Units)
Table 44. APAC Point-of-care Testing (POCT) for Substance Abuse Sales by Application (2018-2023) & (K Units)
Table 45. Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2018-2023) & (K Units)
Table 46. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country (2018-2023)
Table 47. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country (2018-2023)
Table 49. Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Type (2018-2023) & (K Units)
Table 50. Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Point-of-care Testing (POCT) for Substance Abuse
Table 58. Key Market Challenges & Risks of Point-of-care Testing (POCT) for Substance Abuse
Table 59. Key Industry Trends of Point-of-care Testing (POCT) for Substance Abuse
Table 60. Point-of-care Testing (POCT) for Substance Abuse Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Point-of-care Testing (POCT) for Substance Abuse Distributors List
Table 63. Point-of-care Testing (POCT) for Substance Abuse Customer List
Table 64. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Roche Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 79. Roche Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 80. Roche Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Danaher Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 84. Danaher Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 85. Danaher Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Danaher Main Business
Table 87. Danaher Latest Developments
Table 88. Abbott Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 90. Abbott Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Abbott Main Business
Table 92. Abbott Latest Developments
Table 93. Siemens Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 94. Siemens Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 95. Siemens Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Siemens Main Business
Table 97. Siemens Latest Developments
Table 98. Beijing Hotgen Biotech Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 99. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 100. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Beijing Hotgen Biotech Main Business
Table 102. Beijing Hotgen Biotech Latest Developments
Table 103. Hangzhou Biotest Biotech CO.,LTD Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 104. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 105. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Hangzhou Biotest Biotech CO.,LTD Main Business
Table 107. Hangzhou Biotest Biotech CO.,LTD Latest Developments
Table 108. Assure Tech Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 109. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 110. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Assure Tech Main Business
Table 112. Assure Tech Latest Developments
Table 113. Orient Gene Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 114. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 115. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Orient Gene Main Business
Table 117. Orient Gene Latest Developments
Table 118. Thermo Fisher Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 119. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 120. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Thermo Fisher Main Business
Table 122. Thermo Fisher Latest Developments
Table 123. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 124. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 125. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Guangzhou Wondfo Biotech Co.,Ltd. Main Business
Table 127. Guangzhou Wondfo Biotech Co.,Ltd. Latest Developments
Table 128. Hangzhou Alltest Biotech Co.,Ltd. Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 129. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 130. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Hangzhou Alltest Biotech Co.,Ltd. Main Business
Table 132. Hangzhou Alltest Biotech Co.,Ltd. Latest Developments
Table 133. Beckman Coulter Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 134. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 135. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Beckman Coulter Main Business
Table 137. Beckman Coulter Latest Developments
Table 138. Bio-Rad Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 139. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 140. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Bio-Rad Main Business
Table 142. Bio-Rad Latest Developments
Table 143. BioMerieux Basic Information, Point-of-care Testing (POCT) for Substance Abuse Manufacturing Base, Sales Area and Its Competitors
Table 144. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product Portfolios and Specifications
Table 145. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. BioMerieux Main Business
Table 147. BioMerieux Latest Developments
LIST OF FIGURES
Figure 1. Picture of Point-of-care Testing (POCT) for Substance Abuse
Figure 2. Point-of-care Testing (POCT) for Substance Abuse Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Point-of-care Testing (POCT) for Substance Abuse Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Based on Colloidal Gold
Figure 10. Product Picture of Based on Fluorescence Immunochromatography
Figure 11. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type in 2022
Figure 12. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Type (2018-2023)
Figure 13. Point-of-care Testing (POCT) for Substance Abuse Consumed in Hospital
Figure 14. Global Point-of-care Testing (POCT) for Substance Abuse Market: Hospital (2018-2023) & (K Units)
Figure 15. Point-of-care Testing (POCT) for Substance Abuse Consumed in Diagnostic Center
Figure 16. Global Point-of-care Testing (POCT) for Substance Abuse Market: Diagnostic Center (2018-2023) & (K Units)
Figure 17. Point-of-care Testing (POCT) for Substance Abuse Consumed in Road Traffic Safety
Figure 18. Global Point-of-care Testing (POCT) for Substance Abuse Market: Road Traffic Safety (2018-2023) & (K Units)
Figure 19. Point-of-care Testing (POCT) for Substance Abuse Consumed in Military
Figure 20. Global Point-of-care Testing (POCT) for Substance Abuse Market: Military (2018-2023) & (K Units)
Figure 21. Point-of-care Testing (POCT) for Substance Abuse Consumed in Others
Figure 22. Global Point-of-care Testing (POCT) for Substance Abuse Market: Others (2018-2023) & (K Units)
Figure 23. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2022)
Figure 24. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Application in 2022
Figure 25. Point-of-care Testing (POCT) for Substance Abuse Sales Market by Company in 2022 (K Units)
Figure 26. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Company in 2022
Figure 27. Point-of-care Testing (POCT) for Substance Abuse Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Company in 2022
Figure 29. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Point-of-care Testing (POCT) for Substance Abuse Sales 2018-2023 (K Units)
Figure 32. Americas Point-of-care Testing (POCT) for Substance Abuse Revenue 2018-2023 ($ Millions)
Figure 33. APAC Point-of-care Testing (POCT) for Substance Abuse Sales 2018-2023 (K Units)
Figure 34. APAC Point-of-care Testing (POCT) for Substance Abuse Revenue 2018-2023 ($ Millions)
Figure 35. Europe Point-of-care Testing (POCT) for Substance Abuse Sales 2018-2023 (K Units)
Figure 36. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue 2018-2023 ($ Millions)
Figure 39. Americas Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country in 2022
Figure 40. Americas Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country in 2022
Figure 41. Americas Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2018-2023)
Figure 42. Americas Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2018-2023)
Figure 43. United States Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region in 2022
Figure 48. APAC Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Regions in 2022
Figure 49. APAC Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2018-2023)
Figure 50. APAC Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2018-2023)
Figure 51. China Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country in 2022
Figure 59. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country in 2022
Figure 60. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2018-2023)
Figure 61. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2018-2023)
Figure 62. Germany Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2018-2023)
Figure 71. Egypt Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Substance Abuse in 2022
Figure 77. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Substance Abuse
Figure 78. Industry Chain Structure of Point-of-care Testing (POCT) for Substance Abuse
Figure 79. Channels of Distribution
Figure 80. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Forecast by Region (2024-2029)
Figure 81. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Point-of-care Testing (POCT) for Substance Abuse
Figure 2. Point-of-care Testing (POCT) for Substance Abuse Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Point-of-care Testing (POCT) for Substance Abuse Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Based on Colloidal Gold
Figure 10. Product Picture of Based on Fluorescence Immunochromatography
Figure 11. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type in 2022
Figure 12. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Type (2018-2023)
Figure 13. Point-of-care Testing (POCT) for Substance Abuse Consumed in Hospital
Figure 14. Global Point-of-care Testing (POCT) for Substance Abuse Market: Hospital (2018-2023) & (K Units)
Figure 15. Point-of-care Testing (POCT) for Substance Abuse Consumed in Diagnostic Center
Figure 16. Global Point-of-care Testing (POCT) for Substance Abuse Market: Diagnostic Center (2018-2023) & (K Units)
Figure 17. Point-of-care Testing (POCT) for Substance Abuse Consumed in Road Traffic Safety
Figure 18. Global Point-of-care Testing (POCT) for Substance Abuse Market: Road Traffic Safety (2018-2023) & (K Units)
Figure 19. Point-of-care Testing (POCT) for Substance Abuse Consumed in Military
Figure 20. Global Point-of-care Testing (POCT) for Substance Abuse Market: Military (2018-2023) & (K Units)
Figure 21. Point-of-care Testing (POCT) for Substance Abuse Consumed in Others
Figure 22. Global Point-of-care Testing (POCT) for Substance Abuse Market: Others (2018-2023) & (K Units)
Figure 23. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2022)
Figure 24. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Application in 2022
Figure 25. Point-of-care Testing (POCT) for Substance Abuse Sales Market by Company in 2022 (K Units)
Figure 26. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Company in 2022
Figure 27. Point-of-care Testing (POCT) for Substance Abuse Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Company in 2022
Figure 29. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Point-of-care Testing (POCT) for Substance Abuse Sales 2018-2023 (K Units)
Figure 32. Americas Point-of-care Testing (POCT) for Substance Abuse Revenue 2018-2023 ($ Millions)
Figure 33. APAC Point-of-care Testing (POCT) for Substance Abuse Sales 2018-2023 (K Units)
Figure 34. APAC Point-of-care Testing (POCT) for Substance Abuse Revenue 2018-2023 ($ Millions)
Figure 35. Europe Point-of-care Testing (POCT) for Substance Abuse Sales 2018-2023 (K Units)
Figure 36. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue 2018-2023 ($ Millions)
Figure 39. Americas Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country in 2022
Figure 40. Americas Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country in 2022
Figure 41. Americas Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2018-2023)
Figure 42. Americas Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2018-2023)
Figure 43. United States Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region in 2022
Figure 48. APAC Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Regions in 2022
Figure 49. APAC Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2018-2023)
Figure 50. APAC Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2018-2023)
Figure 51. China Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country in 2022
Figure 59. Europe Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country in 2022
Figure 60. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2018-2023)
Figure 61. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2018-2023)
Figure 62. Germany Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2018-2023)
Figure 71. Egypt Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Point-of-care Testing (POCT) for Substance Abuse Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Substance Abuse in 2022
Figure 77. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Substance Abuse
Figure 78. Industry Chain Structure of Point-of-care Testing (POCT) for Substance Abuse
Figure 79. Channels of Distribution
Figure 80. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Forecast by Region (2024-2029)
Figure 81. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share Forecast by Application (2024-2029)
